Hepatitis C

Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.
What is Hepatitis C?

Hepatitis C infection is a liver infection caused by the Hepatitis C virus. Infection with hepatitis C may damage the liver leading to chronic infection.

Read More

Overview

Feature Articles

Latest Hepatitis C News and Research

Natural compound 'pheophorbide a' demonstrates robust antiviral activity against SARS-CoV-2 in vitro

Natural compound 'pheophorbide a' demonstrates robust antiviral activity against SARS-CoV-2 in vitro

Grapevine leaf extract inhibits SARS-CoV-2 and HSV-1 replication in the lab

Grapevine leaf extract inhibits SARS-CoV-2 and HSV-1 replication in the lab

Study suggests vitamin B12 as a SARS-CoV-2 antiviral

Study suggests vitamin B12 as a SARS-CoV-2 antiviral

Researcher receives $2.5 million award to curb HIV infection among people who inject drugs

Researcher receives $2.5 million award to curb HIV infection among people who inject drugs

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

Green tea catechins might be useful as pan-coronavirus inhibitors

Green tea catechins might be useful as pan-coronavirus inhibitors

Study finds higher mortality and lower transplant rates among Black patients with cirrhosis

Study finds higher mortality and lower transplant rates among Black patients with cirrhosis

University of Louisville receives NIH funding to support research into liver-related illness

University of Louisville receives NIH funding to support research into liver-related illness

SNPRC at Texas Biomed awarded $37 million NIH grant to continue operations into 2026

SNPRC at Texas Biomed awarded $37 million NIH grant to continue operations into 2026

Alkaloids show potential as treatments for COVID-19

Alkaloids show potential as treatments for COVID-19

Plasma zinc status not an effective prognostic factor for hospitalized COVID-19 patients

Plasma zinc status not an effective prognostic factor for hospitalized COVID-19 patients

USC study suggests new treatment target for Alzheimer's disease in people with APOE4 gene

USC study suggests new treatment target for Alzheimer's disease in people with APOE4 gene

Humoral innate pattern recognition molecules against SARS-CoV-2

Humoral innate pattern recognition molecules against SARS-CoV-2

Clinical trial investigates effectiveness of delivering HIV, substance use care through mobile clinics

Clinical trial investigates effectiveness of delivering HIV, substance use care through mobile clinics

Maternal SARS-CoV-2 infection imprints immune response in the newborn

Maternal SARS-CoV-2 infection imprints immune response in the newborn

Nanopore sequencing contradicts human genome integration of SARS-CoV-2

Nanopore sequencing contradicts human genome integration of SARS-CoV-2

WVU gets ECHO Superhub designation

WVU gets ECHO Superhub designation

Corilagin: could a plant compound used in Chinese herbal medicine help prevent COVID-19?

Corilagin: could a plant compound used in Chinese herbal medicine help prevent COVID-19?

New resolution urges Member States to focus on prevention and management of  diabetes, obesity

New resolution urges Member States to focus on prevention and management of diabetes, obesity

Researchers develop “cell encapsulation” technology to stimulate immunity to fight cancer

Researchers develop “cell encapsulation” technology to stimulate immunity to fight cancer